Riassunto: STEMCELL Technologies annuncia firma del contratto di acquisizione dei cespiti di SQZ Biotechnologies Company

In voller Größe anschauen

Download-Formate

Volle Größe JPEG, 1500x317, 111.1 KB
Klein JPEG, 480x101, 44.6 KB
Vorschau im JPEG-Format JPEG, 144x30, 22.8 KB
Kleinbild im JPEG-Format JPEG, 120x25, 21.4 KB

Smart Multimedia-Galerie

STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders on February 29, 2024, marks another significant milestone for STEMCELL, Canada’s largest biotechnology company. (Photo: Business Wire)